United States · FDA National Drug Code directory
Ibrance
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0069-0688_0bf98e9e-7794-47ec-a88f-2fb726c7861a
- Product NDC
- 0069-0688
- Form
- TABLET, FILM COATED
- Composition / generic term
- palbociclib
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200330
- Source listing expiry
- 20271231
Source-listed ingredients
- PALBOCICLIB — 125 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 DOSE PACK in 1 CARTON (0069-0688-03) / 7 TABLET, FILM COATED in 1 DOSE PACK (0069-0688-07) · 0069-0688-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →